Christopher R Gordon Net Worth & Insider Trades

Christopher R Gordon - Director, Cerevel Therapeutics Holdings, Inc

As of June 16, 2022

What is Christopher R Gordon's Net Worth?

The current estimated net worth of Cerevel Therapeutics Holdings, Inc's Director, Christopher R Gordon, is estimated to be about $107.15B . Christopher R Gordon owns about 60,632,356 units of Cerevel Therapeutics Holdings, Inc common stock. In the last 2 years at Cerevel Therapeutics Holdings, Inc, Christopher R Gordon has sold an estimated value of $0 worth.

What is Christopher R Gordon's Past Insider Trading?

Christopher R Gordon's largest purchase order was 59,961,943 units , worth over $100M on October 29, 2020. In total, Christopher R Gordon has made about 4 transactions over 2 years of their time at Cerevel Therapeutics Holdings, Inc. Christopher R Gordon usually trades in June, with the busiest year in 2020. The most recent transaction was a purchase order of 332,293 units , worth over $3.42M on November 12, 2020.

Christopher R Gordon

Date Range: All Time
Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
Loading...

What is Christopher R Gordon's' Mailing Address?

  • Mailing address is C/o Bain Capital, Llc John Hancock Tower, 200 Clarendon Street Boston MA 02116 MA

What are Cerevel Therapeutics Holdings, Inc's Past Insider Trades?

Cerevel Therapeutics Holdings, Inc's most recent insider trade came on May 8, 2023 by Anthony Coles who sold 50,000 units worth $1.57M . In the last 3 years, insiders at Cerevel Therapeutics Holdings, Inc have sold an estimated value of $29.87M and bought an estimated value of $357.66M worth of shares. Insider trading is most common in February, with the busiest year in 2022. The most active traders at the company are John Renger, Chief Scientific Officer,  Anthony Coles, CEO and Chairperson,  and Abraham Ceesay, President .

Ceres, Inc. Insider Trades

Date Range: All Time
Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
Loading...